You are currently browsing the archives for 26 September 2016.
Displaying 1 entry.

We are delighted to collaborate with Medtronic in this important endeavor.

‘We are delighted to collaborate with Medtronic in this important endeavor,’said Roy Tanaka, President, Biosense Webster, ‘The new strategic alliance will jointly leverage the unique resources and technologies of the two companies and will be of the advantages million patients suffering from cardiac arrhythmias in the world. ‘.

An accompanying commentary an accompanying commentary, Paul Mischel and David Nathanson, at the University of California, Los Angeles, to discuss both the importance of these data for the development of new approaches to the treatment of brain tumors and the potential of this approach applied to the discovery of new druggable targets for other forms of cancer.